Worth a quick skim of the most recent Annual Report & Accounts:
MS Society Annual Report & Accounts
Year end 2018
http://apps.charitycommission.gov.uk/Accounts/Ends57/0001139257_AC_20181231_E_C.PDF
Finance Review
From Page 11
Income
We are delighted that through the extraordinary generosity of our supporters and the MS community we have been able to virtually maintain the 2017 income level in 2018. Income in 2018 was £28.8m as opposed to £28.9m in 2017. This is a good achievement considering the uncertain economic , environment.
Legacies
In 2018 we received over £11.9m from generous supporters who left us gifts in their wills, which was £0.4m higher than 2017. For the third consecutive year we have been grateful to receive one particularly large legacy, meaning legacy income has maintained its high level over the last three years. We are very grateful to everyone who remembered us in their will.
Donations
Once again 2018 saw individuals, friends and organisations undertake a vast range of different activities to raise funds for our vital work, donating an amazing £13.2 million in 2018 (£13.4 million in 2017). Income from charitable activities Income rose to £1.1 m from £950k due to the receipt of two grants via the Big Lottery, one for a project in Wales (My MS, My Rights, My Choices) and another in Manchester on Improving Quality of Life.
Trading activities
Income from trading activities fell to £2.1 m from £2.6m in 2017. In 2017 we held a large £1 m net fundraising event in honour of the late cellist Jacqueline du Pre whose career was cut short by MS. Although we held other large fundraising events in 2018, they were not of the same scale as the 2017 event. Expenditure - changes from 2017 Overall expenditure was similar to 2017 at £29.1 m compared with £28.8m in 2017.
Raising funds (2018: £7.5m; 2017: £7.4m)
Costs remained similar to 2017. There was some additional spend (classified as 'new donor acquisition' in the accounts), some of which related to a major public appeal planned for 2019.
Goal 1 - Effective treatments (2018: £4.0m; 2017: £4.4m)
A major new clinical trial on simvastatin was co-funded by the Society in 2017, costing the MS Society £1.2m, which boosted the 2017 spend on this goal. This is the reason for the slight decrease in 2018.
Goal 2- Responsive care and support (2018: £4.5m; 2017: £4.7m)
Our main areas of responsive care and support are in influencing policy, running our helpline and providing individual support grants to those affected by MS. There was a slight drop in individual support grants awarded in 2018, primarily from grants awarded by our local groups.
Goal 3- Preventing MS (2018: £0.9m; 2017: £ 0.8m)
Most of the money spent on this goal is through research grants we award, and the amount spent can vary year on year. 2017 was lower due to a number of research grant write backs attributed to this goal.
Goal 4- Quality information (2018: £3.8m; 2017: £3.8m)
The award-winning quality information service provided by the society has been maintained during 2018.
Goal 5 -A strong community, independent lives (2018: £6.2m; 2017: £5.7m)
Over half of the spend in this area is either support provided by our local groups or expenditure in supporting them, and there was a slight increase in spend in 2018. There was also an increase in costs on improving our digital resources, which was allocated to this goal.
Goal 6-Supporting families and carers (2018: £1.4m; 2017: £1.4m)
Expenditure on supporting families and carers was maintained in 2018.
Goal 7 - Greater certainty about the future (2018: £0.5m; 2017: £0.5m)
The spend in 2018 was mostly on research grants, with the level of grants awarded similar to 2017. Costs not directly attributed to goals (2018: £4.1m; 2017: £4.2m} These are costs that are apportioned to goals based on staff time or total direct cost as they can't be directly attributed to goals. We continue to look to reduce these costs so more money can be spent directly on our goals. In 2018 these costs fell slightly, primarily due to one-off higher spend on digital costs attributed to IT Support in 2017.